These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9764798)

  • 21. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
    Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
    Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis.
    Goletti D; Carrara S; Vincenti D; Giacomini E; Fattorini L; Garbuglia AR; Capobianchi MR; Alonzi T; Fimia GM; Federico M; Poli G; Coccia E
    J Infect Dis; 2004 Feb; 189(4):624-33. PubMed ID: 14767815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV replication in labile equilibrium].
    Praxis (Bern 1994); 1997 Sep; 86(39):1525. PubMed ID: 9411674
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of HIV infection by the cytokine midkine.
    Callebaut C; Nisole S; Briand JP; Krust B; Hovanessian AG
    Virology; 2001 Mar; 281(2):248-64. PubMed ID: 11277697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nefarious abuse.
    Pope M
    Nat Immunol; 2003 Aug; 4(8):729-30. PubMed ID: 12888792
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV-1 Nef protein: An invitation to a kill.
    Cullen BR
    Nat Med; 1999 Sep; 5(9):985-6. PubMed ID: 10470067
    [No Abstract]   [Full Text] [Related]  

  • 27. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
    Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages.
    Nguyen DG; Hildreth JE
    Eur J Immunol; 2003 Feb; 33(2):483-93. PubMed ID: 12645947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
    Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
    J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of HIV-1 replication by allogeneic stimulation.
    Moriuchi H; Moriuchi M; Fauci AS
    J Immunol; 1999 Jun; 162(12):7543-8. PubMed ID: 10358210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells.
    Ancuta P; Kunstman KJ; Autissier P; Zaman T; Stone D; Wolinsky SM; Gabuzda D
    Virology; 2006 Jan; 344(2):267-76. PubMed ID: 16305804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
    Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
    Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-AIDS agents. Part 58: synthesis and anti-HIV activity of 1-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (1-thia-DCK) analogues.
    Xia P; Yin ZJ; Chen Y; Zhang Q; Zhang B; Xia Y; Yang ZY; Kilgore N; Wild C; Morris-Natschke SL; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3341-3. PubMed ID: 15149703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-induced leukocyte extract reduces HIV replication and TNF secretion.
    Fernández-Ortega C; Dubed M; Ramos Y; Navea L; Alvarez G; Lobaina L; López L; Casillas D; Rodríguez L
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1075-81. PubMed ID: 15541398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-HIV effect of soy products and possibility of their usage as medicinal and prophylactic nutrition].
    Rybalko SL; Anisimova IuN; Maksimenok EV
    Lik Sprava; 2008; (7-8):63-9. PubMed ID: 19663020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spironolactone: a sleeping pill for HIV in T lymphocytes].
    Lacombe B; Cecilia Ramírez B
    Med Sci (Paris); 2017 Oct; 33(10):846-848. PubMed ID: 28994376
    [No Abstract]   [Full Text] [Related]  

  • 38. Adding fuel to the fire: methamphetamine enhances HIV infection.
    Potula R; Persidsky Y
    Am J Pathol; 2008 Jun; 172(6):1467-70. PubMed ID: 18458093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of effect of desferrioxamine on in-vitro HIV-1 replication.
    Lazdins JK; Alteri E; Klimkait T; Woods-Cook K; Walker MR; Goutte G; Poncioni B
    Lancet; 1991 Nov; 338(8778):1341-2. PubMed ID: 1682729
    [No Abstract]   [Full Text] [Related]  

  • 40. [Do T cells have a potentially unlimited replication capacity?].
    Gensous N; White E; Appay V
    Med Sci (Paris); 2023; 39(8-9):609-611. PubMed ID: 37695148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.